Open access
200
Views
1
CrossRef citations to date
0
Altmetric
Review
Orphan Drugs In Development For The Treatment Of Friedreich’s Ataxia: Focus On Omaveloxolone
Shaila D Ghanekar1 University of South Florida (USF), Department of Neurology, Tampa, FL, USA;2 USF Ataxia Research Center, Department of Neurology, Tampa, FL, USA
, Wai Wai Miller1 University of South Florida (USF), Department of Neurology, Tampa, FL, USA;2 USF Ataxia Research Center, Department of Neurology, Tampa, FL, USA;3 USF Movement Disorders Neuromodulation Center, Department of Neurology, Tampa, FL, USA
https://orcid.org/0000-0003-2913-6676
Colin J Meyer4 Reata Pharmaceuticals, Inc., Department of Product Development, Irving, TX, USA
, Kevin J Fenelon1 University of South Florida (USF), Department of Neurology, Tampa, FL, USA;2 USF Ataxia Research Center, Department of Neurology, Tampa, FL, USA
, Alvin Lacdao1 University of South Florida (USF), Department of Neurology, Tampa, FL, USA;2 USF Ataxia Research Center, Department of Neurology, Tampa, FL, USA
& Theresa A Zesiewicz1 University of South Florida (USF), Department of Neurology, Tampa, FL, USA;2 USF Ataxia Research Center, Department of Neurology, Tampa, FL, USA;3 USF Movement Disorders Neuromodulation Center, Department of Neurology, Tampa, FL, USA;5 James A. Haley Veterans’ Hospital, Department of Neurology, Tampa, FL, USACorrespondence[email protected]
Pages 103-107
|
Published online: 15 Oct 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.